3 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
inhibitors in CVD ... OUTCOME - Empagliflozin ... DECLARE-TIMI 58 - Dapagliflozin ... DAPA-CKD - Dapagliflozin ... #inhibitors #EBM
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors ... gliflozin): • Empagliflozin ... the three • Dapagliflozin ... loss (~2-3kg) • Empagliflozin ... ↓ CV mortality
SGLT2 inhibitors, also called gliflozins, are a class of medications that alter essential physiology of the
SGLT2 inhibitors ... SGLT2 inhibitors ... (Invokana®), dapagliflozin ... (Farxiga®) and empagliflozin ... , #empagliflozin